Heligenics is disrupting and redefining the way genetic information is used in the creation of new drugs at multiple steps along the drug development pipeline. Use our GMLs pre-clinically to minimize adverse events and non-responders before an expensive clinical trial. Our super-precision genetic-based trial design increases safety and efficacy, producing desired outcomes for all phases of a clinical trial.
Redesign a failed clinical trial into a targeted precision trial. Repurpose a drug to maximize profits with our receptor activation maps to experimentally identify off-target receptors and new indications.